150 related articles for article (PubMed ID: 24232077)
1. Formulation and evaluation of liquisolid compacts for olmesartan medoxomil.
Prajapati ST; Bulchandani HH; Patel DM; Dumaniya SK; Patel CN
J Drug Deliv; 2013; 2013():870579. PubMed ID: 24232077
[TBL] [Abstract][Full Text] [Related]
2. Suitability of various excipients as carrier and coating materials for liquisolid compacts.
Hentzschel CM; Sakmann A; Leopold CS
Drug Dev Ind Pharm; 2011 Oct; 37(10):1200-7. PubMed ID: 21449826
[TBL] [Abstract][Full Text] [Related]
3. Application of liquisolid technology for enhancing solubility and dissolution of rosuvastatin.
Kamble PR; Shaikh KS; Chaudhari PD
Adv Pharm Bull; 2014; 4(2):197-204. PubMed ID: 24511485
[TBL] [Abstract][Full Text] [Related]
4. Formulation and evaluation of liquisolid compacts of diclofenac sodium.
Kulkarni AS; Gaja JB
PDA J Pharm Sci Technol; 2010; 64(3):222-32. PubMed ID: 21502022
[TBL] [Abstract][Full Text] [Related]
5. Liquisolid systems to improve the dissolution of furosemide.
Akinlade B; Elkordy AA; Essa EA; Elhagar S
Sci Pharm; 2010; 78(2):325-44. PubMed ID: 21179350
[TBL] [Abstract][Full Text] [Related]
6. Preparation and characterization of liquisolid compacts for improved dissolution of telmisartan.
Chella N; Narra N; Rama Rao T
J Drug Deliv; 2014; 2014():692793. PubMed ID: 25371826
[TBL] [Abstract][Full Text] [Related]
7. Enhancement of dissolution rate of piroxicam using liquisolid compacts.
Javadzadeh Y; Siahi-Shadbad MR; Barzegar-Jalali M; Nokhodchi A
Farmaco; 2005 Apr; 60(4):361-5. PubMed ID: 15848213
[TBL] [Abstract][Full Text] [Related]
8. The effect of type and concentration of vehicles on the dissolution rate of a poorly soluble drug (indomethacin) from liquisolid compacts.
Nokhodchi A; Javadzadeh Y; Siahi-Shadbad MR; Barzegar-Jalali M
J Pharm Pharm Sci; 2005 Jan; 8(1):18-25. PubMed ID: 15946594
[TBL] [Abstract][Full Text] [Related]
9. Design and Characterization of Buccoadhesive Liquisolid System of an Antihypertensive Drug.
Kala NP; Shastri DH; Shelat PK
J Drug Deliv; 2015; 2015():574247. PubMed ID: 26579235
[TBL] [Abstract][Full Text] [Related]
10. Enhancement of griseofulvin release from liquisolid compacts.
Hentzschel CM; Alnaief M; Smirnova I; Sakmann A; Leopold CS
Eur J Pharm Biopharm; 2012 Jan; 80(1):130-5. PubMed ID: 21846502
[TBL] [Abstract][Full Text] [Related]
11. Liquisolid technique as a tool for enhancement of poorly water-soluble drugs and evaluation of their physicochemical properties.
Javadzadeh Y; Siahi MR; Asnaashari S; Nokhodchi A
Acta Pharm; 2007 Mar; 57(1):99-109. PubMed ID: 19839410
[TBL] [Abstract][Full Text] [Related]
12. Liquisolid Tablets for Dissolution Enhancement of a Hypolipidemic Drug.
Patel DS; Pipaliya RM; Surti N
Indian J Pharm Sci; 2015; 77(3):290-8. PubMed ID: 26180274
[TBL] [Abstract][Full Text] [Related]
13. An investigation of physicochemical properties of piroxicam liquisolid compacts.
Javadzadeh Y; Siahi MR; Asnaashari S; Nokhodchi A
Pharm Dev Technol; 2007; 12(3):337-43. PubMed ID: 17613897
[TBL] [Abstract][Full Text] [Related]
14. Formulation Development of Mirtazapine Liquisolid Compacts: Optimization Using Central Composite Design.
Naureen F; Shah Y; Shah SI; Abbas M; Rehman IU; Muhammad S; Hamdullah H; Goh KW; Khuda F; Khan A; Chan SY; Mushtaq M; Ming LC
Molecules; 2022 Jun; 27(13):. PubMed ID: 35807252
[TBL] [Abstract][Full Text] [Related]
15. Formulation and characterization of ketoprofen liquisolid compacts by Box-Behnken design.
Vittal GV; Deveswaran R; Bharath S; Basavaraj B; Madhavan V
Int J Pharm Investig; 2012 Jul; 2(3):150-6. PubMed ID: 23373006
[TBL] [Abstract][Full Text] [Related]
16. Liquisolid technique for dissolution rate enhancement of a high dose water-insoluble drug (carbamazepine).
Javadzadeh Y; Jafari-Navimipour B; Nokhodchi A
Int J Pharm; 2007 Aug; 341(1-2):26-34. PubMed ID: 17498898
[TBL] [Abstract][Full Text] [Related]
17. Effects of liquisolid formulations on dissolution of naproxen.
Tiong N; Elkordy AA
Eur J Pharm Biopharm; 2009 Nov; 73(3):373-84. PubMed ID: 19679184
[TBL] [Abstract][Full Text] [Related]
18. Investigating the use of liquisolid compacts technique to minimize the influence of pH variations on loratadine release.
El-Hammadi M; Awad N
AAPS PharmSciTech; 2012 Mar; 13(1):53-8. PubMed ID: 22101967
[TBL] [Abstract][Full Text] [Related]
19. Enhancement of dissolution rate of indomethacin: using liquisolid compacts.
Saeedi M; Akbari J; Morteza-Semnani K; Enayati-Fard R; Sar-Reshteh-Dar S; Soleymani A
Iran J Pharm Res; 2011; 10(1):25-34. PubMed ID: 24363677
[TBL] [Abstract][Full Text] [Related]
20. Formulation factors affecting the release of ezetimibe from different liquisolid compacts.
Khanfar M; Sheikh Salem M; Hawari R
Pharm Dev Technol; 2013; 18(2):417-27. PubMed ID: 22530561
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
